Johnson & Johnson (J&J) recently announced a collaboration between Janssen Pharmaceuticals and Emergent BioSolutions to support the manufacturing of its lead investigational COVID-19 vaccine...
Novartis recently announced its commitment to donate up to 130 million doses of generic hydroxychloroquine, a potential COVID-19 treatment.
For more coronavirus updates, visit our resource...
Pharmacy benefit manager (PBM) reimbursement for generic drugs significantly varies by medication and plan, and does not respond to price hikes, according to a study from 3 Axis Advisors.
Researchers...
Repurposed generics show promise as potential COVID-19 drugs and may be manufactured profitably at very low costs, according to a recent study.
For more coronavirus updates, visit...
A recent study found that 68 percent of COVID-19 patients who received compassionate-use remdesivir showed clinical improvement, but measurements of efficacy will require ongoing controlled trials to...
A treatment for hemophilia is the latest FDA approval seeking to improve chronic disease management.
FDA recently approved Sevenfact for the treatment of hemophilia A or B with inhibitors in adults...
Alnylam and Dicerna recently announced the development and commercialization of investigational RNAi therapeutics for the treatment of alpha-1 liver disease.
The pharmaceutical companies have also...
The American Society of Health-System Pharmacists (ASHP) recently called on the Trump Administration to address shortages of supportive ventilator drugs as COVID-19 continues to infect more...
Gilead will expand access to potential COVID-19 treatment, remdesivir, for patients with the greatest need, according to an official letter from Daniel O’Day, Gilead chairman and CEO.
For more...
The FDA finally approved Zeposia (ozanimod), a multiple sclerosis (MS) drug developed by Celgene, according to a recent announcement from the Bristol-Myers Squibb Company.
Bristol-Myers acquired...
CVS Caremark, the pharmacy benefit manager business of CVS Health, recently announced that it is working with clients to implement new measures to protect and strengthen the COVID-19 supply chain,...
Biosimilar reviews confirm any differences between a potential biosimilar and its reference product, but new research shows that these reviews may need to provide more information about efficacy to...
The US Food and Drug Administration (FDA) and the Federal Trade Commission (FTC) issued warning letters to seven companies for selling false coronavirus (COVID-19) drugs, vaccines, and other products,...
Manufacturers increased prescription drug prices for four drugs commonly used by hospitals after receiving FDA approval, creating an estimated $20.25 billion in additional healthcare spending over...
The Department of Justice recently announced that it has charged generic pharmaceutical company Sandoz Inc. for fixing generic drug prices, rigging bids, and other antitrust...
The net cost of prescription drugs rose over three times faster than the rate of inflation over the last decade, according to researchers from the University of Pittsburgh’s Health Policy...
The Institute for Clinical and Economic Review’s (ICER) final evidence report assessing the clinical effectiveness and economic value of three acute treatments for migraines had more favorable...
Law firm Lieff Cabraser, Heimann & Bernstein recently filed a wrongful death lawsuit against biopharmaceutical manufacturer Alkermes, for its alleged misrepresentation of an opioid dependence drug,...
GW Pharmaceuticals announced last week that its cannabinoid (CBD) prescription medicines brought in total revenue of $109.1 million for the fourth quarter of 2019, and $311.3 million for the full...
Germany-based pharmaceutical company, Stada, announced it acquired 15 well-established local and regional consumer over-the-counter (OTC) products from GlaxoSmithKline (GSK).
The proposed...
